CORONAVIRIDAE
Family consists of
1. Genus _________- spike protein - corona
2. Genus _________ - enteric infection
CORONAVIRUS REPLICATION
1. Receptor for human coronavirus 229E is _________–
2. Functional receptor for SARS-COV is ___________
3. Receptor for MERS-COV is ____________- aka CD26
REPLICATION CYCLE
Virus absorbs to cells via its spikes (___________) enters cytoplasm and uncoatinmg
Hemagluttinin
SARS PATHOGENESIS
1. Infection is mediated by _________- receptor
2. High expression in the __________ cells
3. Low expression in the ______________
SEVERE ACUTE RESPIRATORY VIRUS
1. SARS COV infects both the ____ and ____ airway and _________ cells and creates lung injury
2. Virus and viral products are detected in the kidney, liver, small intestine and stool
3. Lung is severely affected and the level of infectious virus diminished as the clinical disease worsens
MERS COV TROPISM
In humans the virus has strong tropism for __________ and it has been shown to effectively evade the innate immune responses and antagonize _____________ production in these cells
In humans the virus has strong tropism for NONCILIATED BRONCHIAL EPITHELIAL CELLS and it has been shown to effectively evade the innate immune responses and antagonize INTERFERON production in these cells
TROPISM OF MERS COV
However it was late discovered that MERS-COV receptor is _____, a dipeptyl peptidase which is involved in the degranulation of cytokine responses
CD26
LABORATORY DIAGNOSIS
1._________ is currently the only test being used to confirm cases of COVID-19 infection
2. ______ is the 1st choice
INVESTIGATIONAL THERAPEUTICS
1. _________- producing premature termination of viral chain
INVESTIGATIONAL THERAPEUTICS
1.__________- a combined protease inhibitor usually used for HIV infection
2. __________-is an anti-IL6 receptor agent used for rheumatoid arthritis being investigated in patients with COVID-19 presenting with high IL-6 levels
3._________- a TMPRSS2 inhibitor is reported to block viral entry by inhibiting S protein priming